BlackRock Portfolio holdings
AUM
$5.23T
1-Year Return
24.48%
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
This Quarter Return
+10.7%
1 Year Return
+24.48%
3 Year Return
+103%
5 Year Return
+187.44%
10 Year Return
+430.33%
AUM
$2.69T
AUM Growth
+$204B
(+8.2%)
Cap. Flow
+$492M
Cap. Flow
% of AUM
0.02%
Top 10 Holdings %
Top 10 Hldgs %
19.5%
Holding
5,172
New
192
Increased
1,726
Reduced
2,546
Closed
177
Top Buys
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$2.37B |
| 2 |
Zoom
ZM
|
+$1.88B |
| 3 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$1.5B |
| 4 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$1.43B |
| 5 |
SPDR Bloomberg High Yield Bond ETF
JNK
|
+$1.24B |
Top Sells
| 1 |
Apple
AAPL
|
+$3.71B |
| 2 |
Microsoft
MSFT
|
+$1.21B |
| 3 |
IAC Inc
IAC
|
+$1.2B |
| 4 |
Amazon
AMZN
|
+$809M |
| 5 |
Meta Platforms (Facebook)
META
|
+$765M |
Sector Composition
| 1 | Technology | 22.69% |
| 2 | Healthcare | 14.52% |
| 3 | Consumer Discretionary | 12.01% |
| 4 | Financials | 11.66% |
| 5 | Communication Services | 8.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3026
Western New England Bancorp
WNEB
$250M
| $12.3M | ﹤0.01% |
2,182,023
+60,032
| +3% | +$338K |
|
|
AWH
3027
DELISTED
Aspira Women's Health Inc. Common Stock
AWH
| $12.3M | ﹤0.01% |
265,249
+102,694
| +63% | +$4.75M |
|
|
HMHC
3028
DELISTED
Houghton Mifflin Harcourt Company
HMHC
| $12.2M | ﹤0.01% |
7,075,034
-204,852
| -3% | -$354K |
|
3029
Paysign
PAYS
$310M
| $12.2M | ﹤0.01% |
2,150,227
-52,945
| -2% | -$301K |
|
3030
Primis Financial Corp
FRST
$269M
| $12.1M | ﹤0.01% |
1,399,069
+78,811
| +6% | +$684K |
|
3031
Uranium Energy
UEC
$5.16B
| $12.1M | ﹤0.01% |
12,170,415
-111,442
| -0.9% | -$111K |
|
|
NIU
3032
Niu Technologies
NIU
$326M
| $12.1M | ﹤0.01% |
630,821
+150,020
| +31% | +$2.88M |
|
|
ODT
3033
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
| $12.1M | ﹤0.01% |
901,464
+2,627
| +0.3% | +$35.3K |
|
|
ITI
3034
DELISTED
Iteris, Inc.
ITI
| $12.1M | ﹤0.01% |
2,950,668
+97,665
| +3% | +$400K |
|
3035
National CineMedia
NCMI
$455M
| $12.1M | ﹤0.01% |
444,185
-42,175
| -9% | -$1.15M |
|
3036
Spero Therapeutics
SPRO
$107M
| $12M | ﹤0.01% |
1,077,162
+126,906
| +13% | +$1.42M |
|
3037
Dianthus Therapeutics
DNTH
$1.48B
| $12M | ﹤0.01% |
110,463
+10,374
| +10% | +$1.13M |
|
3038
Main Street Capital
MAIN
$5.97B
| $12M | ﹤0.01% |
405,657
+42,156
| +12% | +$1.25M |
|
|
GTH
3039
DELISTED
Genetron Holdings Limited ADS
GTH
| $12M | ﹤0.01% |
334,093
-3,155
| -0.9% | -$113K |
|
|
RBNC
3040
DELISTED
Reliant Bancorp, Inc. Common Stock
RBNC
| $11.9M | ﹤0.01% |
821,008
-32,653
| -4% | -$473K |
|
3041
VEON
VEON
$3.7B
| $11.9M | ﹤0.01% |
377,740
-324,076
| -46% | -$10.2M |
|
3042
Rush Enterprises Class B
RUSHB
$4.49B
| $11.8M | ﹤0.01% |
600,863
-14,049
| -2% | -$277K |
|
|
VWTR
3043
DELISTED
Vidler Water Resouces, Inc. Common Stock
VWTR
| $11.8M | ﹤0.01% |
1,316,500
-7,006
| -0.5% | -$62.8K |
|
3044
Bentley Systems
BSY
$16.1B
| $11.8M | ﹤0.01% |
+375,001
| New | +$11.8M |
|
3045
Aprea Therapeutics
APRE
$9.15M
| $11.8M | ﹤0.01% |
24,424
+449
| +2% | +$216K |
|
3046
Transcat
TRNS
$701M
| $11.7M | ﹤0.01% |
400,770
-5,633
| -1% | -$165K |
|
3047
Celldex Therapeutics
CLDX
$1.63B
| $11.7M | ﹤0.01% |
791,596
+379,144
| +92% | +$5.62M |
|
|
CSTR
3048
DELISTED
CapStar Financial Holdings, Inc
CSTR
| $11.7M | ﹤0.01% |
1,195,003
-10,172
| -0.8% | -$99.8K |
|
3049
Vanguard Extended Market ETF
VXF
$24.3B
| $11.7M | ﹤0.01% |
90,153
+5,100
| +6% | +$662K |
|
|
EVFM
3050
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
| $11.7M | ﹤0.01% |
330,262
+141,340
| +75% | +$5M |
|